Keep CALM and Trade On – QAV America #25

In this episode of *QAV America* (Ep. 25), Cameron and Tony unpack a wild few weeks in the U.S. markets following Donald Trump’s latest tariff threats on China and the subsequent “birthday crash.” They discuss Australia’s surprising role in rare earths, portfolio moves including DAC and GTN, and new additions VSAT and RNR. The main feature is a deep dive into Cal-Maine Foods (ticker: CALM), America’s largest egg producer, exploring its scandal-ridden history, DOJ investigations, and surprising fundamentals. From “egg cartels” to F-scores, the duo balance analysis and absurdity, topping it off with film talk (Scorsese, Lynch) and kung fu bruises.

QAV America 24 – The Beauty of Boring: American Axle (AXL)

In this episode of QAV America, Cameron and Tony review the US portfolio’s performance in 2025, which—despite lagging this year—is still well ahead of the S&P 500 since inception. They reflect on past stock picks, showing a mixed bag of winners and losers, before diving into this week’s “Pulled Pork”: Community Health Systems (NYSE: CYH). The discussion ranges from the messiness of America’s healthcare system to the company’s staggering debt load, CEO transition, scandals, and surprisingly strong cashflow. They weigh the risks (reimbursement uncertainty, capital raises, softening acuity mix) against the opportunities (deep undervaluation, strong operating cash generation, potential turnaround with new leadership). Along the way, they also touch on cultural differences in healthcare, Reddit debates about value investing, and how profit is often a “management decision,” while cashflow is the truer measure of resilience.

QAV America 23 – For-Profit Healthcare: CYH

In this episode of QAV America, Cameron and Tony review the US portfolio’s performance in 2025, which—despite lagging this year—is still well ahead of the S&P 500 since inception. They reflect on past stock picks, showing a mixed bag of winners and losers, before diving into this week’s “Pulled Pork”: Community Health Systems (NYSE: CYH). The discussion ranges from the messiness of America’s healthcare system to the company’s staggering debt load, CEO transition, scandals, and surprisingly strong cashflow. They weigh the risks (reimbursement uncertainty, capital raises, softening acuity mix) against the opportunities (deep undervaluation, strong operating cash generation, potential turnaround with new leadership). Along the way, they also touch on cultural differences in healthcare, Reddit debates about value investing, and how profit is often a “management decision,” while cashflow is the truer measure of resilience.